advertisement
Supuran CT 22
Showing records 1 to 22 | Display all abstracts from Supuran CT116916 Novel Carbonic Anhydrase Inhibitors with Dual-Tail Core Sulfonamide Show Potent and Lasting Effects for Glaucoma Therapy
Angeli A
Journal of Medicinal Chemistry 2024; 67: 3066-3089
117002 Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma
Tawfik HO
Journal of Medicinal Chemistry 2024; 67: 1611-1623
118619 Carbonic anhydrase, its inhibitors and vascular function
García-Llorca A
Frontiers in molecular biosciences 2024; 11: 1338528
116916 Novel Carbonic Anhydrase Inhibitors with Dual-Tail Core Sulfonamide Show Potent and Lasting Effects for Glaucoma Therapy
Chelli I
Journal of Medicinal Chemistry 2024; 67: 3066-3089
118619 Carbonic anhydrase, its inhibitors and vascular function
Carta F
Frontiers in molecular biosciences 2024; 11: 1338528
117002 Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma
Saleh MM
Journal of Medicinal Chemistry 2024; 67: 1611-1623
116916 Novel Carbonic Anhydrase Inhibitors with Dual-Tail Core Sulfonamide Show Potent and Lasting Effects for Glaucoma Therapy
Lucarini L
Journal of Medicinal Chemistry 2024; 67: 3066-3089
118619 Carbonic anhydrase, its inhibitors and vascular function
Supuran CT
Frontiers in molecular biosciences 2024; 11: 1338528
117002 Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma
Ammara A; Khaleel EF
Journal of Medicinal Chemistry 2024; 67: 1611-1623
118619 Carbonic anhydrase, its inhibitors and vascular function
Eysteinsson T
Frontiers in molecular biosciences 2024; 11: 1338528
116916 Novel Carbonic Anhydrase Inhibitors with Dual-Tail Core Sulfonamide Show Potent and Lasting Effects for Glaucoma Therapy
Sgambellone S; Marri S
Journal of Medicinal Chemistry 2024; 67: 3066-3089
117002 Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma
Badi R
Journal of Medicinal Chemistry 2024; 67: 1611-1623
116916 Novel Carbonic Anhydrase Inhibitors with Dual-Tail Core Sulfonamide Show Potent and Lasting Effects for Glaucoma Therapy
Villano S
Journal of Medicinal Chemistry 2024; 67: 3066-3089
117002 Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma
Khater YTT; Rasheed RA
Journal of Medicinal Chemistry 2024; 67: 1611-1623
116916 Novel Carbonic Anhydrase Inhibitors with Dual-Tail Core Sulfonamide Show Potent and Lasting Effects for Glaucoma Therapy
Ferraroni M; De Luca V
Journal of Medicinal Chemistry 2024; 67: 3066-3089
117002 Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma
Attia AA
Journal of Medicinal Chemistry 2024; 67: 1611-1623
116916 Novel Carbonic Anhydrase Inhibitors with Dual-Tail Core Sulfonamide Show Potent and Lasting Effects for Glaucoma Therapy
Capasso C
Journal of Medicinal Chemistry 2024; 67: 3066-3089
117002 Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma
Hefny SM; Elkaeed EB
Journal of Medicinal Chemistry 2024; 67: 1611-1623
116916 Novel Carbonic Anhydrase Inhibitors with Dual-Tail Core Sulfonamide Show Potent and Lasting Effects for Glaucoma Therapy
Carta F
Journal of Medicinal Chemistry 2024; 67: 3066-3089
117002 Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma
Nocentini A
Journal of Medicinal Chemistry 2024; 67: 1611-1623
116916 Novel Carbonic Anhydrase Inhibitors with Dual-Tail Core Sulfonamide Show Potent and Lasting Effects for Glaucoma Therapy
Supuran CT
Journal of Medicinal Chemistry 2024; 67: 3066-3089
117002 Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma
Supuran CT; Eldehna WM; Shaldam MA
Journal of Medicinal Chemistry 2024; 67: 1611-1623